EBS News - Candlesense

Emergent BioSolutions Underscores Continued Support of Increasing Naloxone Awareness Through Public Education Campaign on International Overdose Awareness Day

(NYSE:EBS) GAITHERSBURG, Md., Aug. 29, 2025 (GLOBE NEWSWIRE) -- In honor of International Overdose Awareness Day (IOAD) on August 31, Emergent BioSolutions (NYSE: EBS) is re-launching its Ready t...

Awareness

about 8 hours ago

Read more globenewswire

Emergent BioSolutions to Participate in Upcoming Investor Conferences

GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following ...

Investor

2 days ago

Read more globenewswire

Emergent BioSolutions Supports Voices for Awareness and Facing Fentanyl Now on August 21, 2025 for National Fentanyl Prevention and Awareness Day™

GAITHERSBURG, Md., Aug. 21, 2025 (GLOBE NEWSWIRE) -- As opioid emergencies continue to be the leading cause of accidental death in the United States,1 Emergent BioSolutions (NYSE: EBS) is teaming...

Awareness

8 days ago

Read more globenewswire

Emergent BioSolutions Reports Second Quarter 2025 Financial Results

GAITHERSBURG, Md., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today reported financial results for the second quarter ended June 30, 2025.

What risks or uncertainties did management highlight that could affect future performance? How does the quarter’s performance affect the company's long‑term growth trajectory and dividend policy? What are the potential implications of the earnings release on the broader sector sentiment and related stocks?

Earnings

23 days ago

Read more globenewswire